Current management of lupus nephritis: popular misconceptions.

about

Changes in the incidence of endstage renal disease due to lupus nephritis in the United States, 1996-2004.

P2860

Q37185798-B21A1D78-5DDC-4D13-AA42-A22D73FDB6A3

P2860

Current management of lupus nephritis: popular misconceptions.

Item

http://www.wikidata.org/entity/Q36790809

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Current management of lupus nephritis: popular misconceptions.

@ast

Current management of lupus nephritis: popular misconceptions.

@en

type

Item

label

Current management of lupus nephritis: popular misconceptions.

@ast

Current management of lupus nephritis: popular misconceptions.

@en

prefLabel

Current management of lupus nephritis: popular misconceptions.

@ast

Current management of lupus nephritis: popular misconceptions.

@en

P1476

Current management of lupus nephritis: popular misconceptions.

@en

P2093

D Jayne

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials.

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation.

Mycophenolate mofetil combined with prednisone for diffuse proliferative lupus nephritis: a histopathological study.

Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.

Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation.

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.

Mortality and causes of death in systemic lupus erythematosus.

P304

217-220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0961203306075614

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6396583

http://www.w3.org/2001/XMLSchema#string

P698

17432110

http://www.w3.org/2001/XMLSchema#string

Current management of lupus nephritis: popular misconceptions.

about

P2860

P2860

Current management of lupus nephritis: popular misconceptions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698